期刊文献+

阻塞性睡眠呼吸暂停综合征合并高血压患者颈动脉内皮功能和血清C-反应蛋白水平变化的意义 被引量:1

Analysis the correlation between serum C-reactive protein and IMT in patients with OSAS complicating with essential hypertension
下载PDF
导出
摘要 目的探讨在阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea syndrome,OSAS)合并高血压患者血清C-反应蛋白(CRP)及颈动脉内膜中层厚度(IMT)的变化及相互关系。方法采用高分辨率超声检测健康对照组、OSAS组、高血压组和OSAS合并高血压组患者IMT。采用速率散射免疫比浊法检测各组患者血清CRP水平。结果 OSAS合并高血压组患者IMT、血清CRP水平显著高于健康对照组、单纯OSAS组和单纯高血压组(P<0.05)。检验结果显示,CRP升高与IMT之间有统计学意义(P<0.05),OR(95%CI)为4.329(3.837~5.641)。结论血清CRP水平可以作为OSAS合并高血压患者将来发生心血管病变的预测指标。 Objective To investigate the correlation between C-reactive protein (CRP) and carotid arterial intimamadia thickness (IMT) of patients with obstructive sleep apnea syndrome. Methods The carotid arterial intimamadia thickness was determined by high resolution ultrasonography. The serous concentration of C-reactive protein was detected by velocity scatter immunoturbidimetry. Results Compared with health control group, OSAS group, and essential hypertension (EH) group, IMT were significantly greater in patients with OSAS + EH (P 〈 0. 05 ) ; CRP were significantly higher (P 〈 0. 05 ). The results showed that significant linear association between CRP and IMT. Conclusion Serous concentration of CRP is an prognostic indicatrix for patients with OSAS + EH.
作者 兰世才
出处 《四川医学》 CAS 2012年第7期1240-1242,共3页 Sichuan Medical Journal
关键词 阻塞性睡眠呼吸暂停综合征 血清C-反应蛋白 颈动脉内膜中层厚度 obstructive sleep apnea syndrome serum C-reactive protein carotid arterial intimamadia thickness
  • 相关文献

参考文献11

  • 1戈晓华,齐建鹰,邹艳秋.高血压病患者颈动脉超声检测分析[J].医学影像学杂志,1997,7(1):17-19. 被引量:10
  • 2Logan AG, Perlikowski SM, Mente A, et al. High prevalence of un- recognized sleep apneea in drug-resistant hypertension [ J ]. Hyper- tens, 2001, 19(12): 2271 -2277.
  • 3Ohayon MM, Guilleminault C, Priest RG, et al. Is sleep-disordered breathing an independent risk factor for hypertension in the general population ( 13,057 subjects ) [ J ]. Psyehosom Res, 2000,48 ( 6 ) : 593 ~ 601.
  • 4王英,杨海波,董明敏.阻塞性睡眠呼吸暂停综合征患者超敏C反应蛋白及纤溶活性的研究[J].临床耳鼻咽喉科杂志,2004,18(3):147-148. 被引量:13
  • 5Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syn- drome are decreased by nasal continuous positive airway pressure[ J]. Circulation, 2003,107 ( 8 ) : 1129 - 1134.
  • 6Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[ J]. Circulation,2002,105(9) : 1135 - 1143.
  • 7Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of athero- sclerosis in obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2005, 172(5) : 613 ~618.
  • 8Ghiadoni L, Taddei S, Virdis A, et al. Endothelial function and com- mon carotid artery wall thickening in patients with essential hyperten- sion[J]. Hypertension, 1998, 32(1 ) : 25 ~32.
  • 9Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea [J]. Adv Cat'did, 2011,46(1) : 139 ~170.
  • 10Oflaz H, Cuhadaroglu C, Pamukcu B, et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hyperten- sion[J]. Respiration,2006,73(6) : 751 ~756.

二级参考文献7

  • 1[3]Hartmann G,Tschop M,Fischer R,et al.High altitude increase circulating interleukin-6,interleulin-1 receptor antagonist and C-reactive protein.Cytokine,2000,12:246-252.
  • 2[4]Vgontzas A N,Papanicolaou D A,Bixler E O,et al.Circadian interleukin-6 secretion and quantity and depth of sleep.J Clin Endocrinol Metab,1999,84:2603-2607.
  • 3[5]Shearer W T,Reuben J M,Mullington J M,et al.Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.J Allergy Clin Immunol,2001,107:165-170.
  • 4[6]Shamsuzzaman A S,Winnicki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea.Circulation,2002,105:2462-2464.
  • 5[7]Rangemark C,Hedner J A,Carlson J T,et al.Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.Sleep,1995,18:188-194.
  • 6[1]Ridker P M.High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.Circulation,2001,103:1813-1818.
  • 7[2]Albert M A,Danielson E,Rifai N,et al.Effect of statin therapy on C-reactive protein levels:the pravastatin inflammation/CRP evaluation(PRINCE) :a randomized trial and cohort study.JAMA,2001,286:64-70.

共引文献21

同被引文献20

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部